论文信息 - 2MO Final OS results and subgroup analysis of savolitinib in patients with MET exon 14 skipping mutations (METex14+) NSCLC - 字舞流文

2MO Final OS results and subgroup analysis of savolitinib in patients with MET exon 14 skipping mutations (METex14+) NSCLC

H. Zhang | N. Yang | Yuxiang Chen | Y. Cheng | L. Jiang | Z. Liang | J. Fang | Y. Fan | G. Chen | J. Shi | R. Ma | X. Li | Q. Guo | L. Cao | S. Lu | Z. Han | J. Zhou | H. Xu | S. Sun | S. Weiguo